Theriva Biologics, Inc. (TOVX) Misses Q2 EPS by 24c
Tweet
Share
E-mailGet Alerts TOVX Hot Sheet
Join SI Premium – FREE
Theriva Biologics, Inc. (NYSE: TOVX) reported Q2 EPS of ($0.43), $0.24 worse than the analyst estimate of ($0.19).
For earnings history and earnings-related data on Theriva Biologics, Inc. (TOVX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Costco (COST) Tops Q4 EPS by 20c
- SonicStrategy buys 260,000 more SYN tokens, grants stock options
- Northrop Grumman wins three U.S. defense contracts worth $308M
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
